Prognostic usefulness of the change in n-terminal pro b-type natriuretic peptide levels to predict mortality in a single community cohort aged ≥70 years

American Journal of Cardiology

Volumn 111, Issue 1, 2013, Pages 131-136

  Eggers, Kai M ^a   Venge, Per ^a   Lind, Lars ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GENDER; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL;

AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE; SWEDEN;

EID: 84870998163     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.08.058     Document Type: Article

References (23)

1. R.S. Vasan, E.J. Benjamin, M.G. Larson, E.P. Leip, T.J. Wang, P.W. Wilson, and D. Levy Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham study JAMA 288 2002 1252 1259
2. G.I. Galasko, A. Lahiri, S.C. Barnes, P. Collinson, and R. Senior What is the normal range for N-terminal pro-brain natriuretic peptide? How well does this normal range screen for cardiovascular disease? Eur Heart J 26 2005 2269 2276
3. L.C. Costello-Boerrigter, G. Boerrigter, M.M. Redfield, R.J. Rodeheffer, L.H. Urban, D.W. Mahoney, S.J. Jacobsen, D.M. Heublein, and J.C. Burnett Jr. Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction J Am Coll Cardiol 47 2006 345 353
4. W.P. Abhayaratna, T.H. Marwick, N.G. Becker, I.M. Jeffery, D.A. McGill, and W.T. Smith Population-based detection of systolic and diastolic dysfunction with amino-terminal pro-B-type natriuretic peptide Am Heart J 152 2006 941 948
5. B. Zethelius, L. Berglund, J. Sundström, E. Ingelsson, S. Basu, A. Larsson, P. Venge, and J. Arnlöv Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116
6. J.A. de Lemos, D.K. McGuire, A. Khera, S.R. Das, S.A. Murphy, T. Omland, and M.H. Drazner Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: results from the Dallas Heart Study Am Heart J 157 2009 746 753.e2
7. S. Blankenberg, T. Zeller, O. Saarela, A.S. Havulinna, F. Kee, H. Tunstall-Pedoe, K. Kuulasmaa, J. Yarnell, R.B. Schnabel, P.S. Wild MORGAM Project Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project Circulation 121 2010 2388 2397
8. C.R. deFilippi, R.H. Christenson, J.S. Gottdiener, W.J. Kop, and S.L. Seliger Dynamic cardiovascular risk assessment in elderly people: the role of repeated N-terminal pro-B-type natriuretic peptide testing J Am Coll Cardiol 55 2010 441 450
9. L. Lind, N. Fors, J. Hall, K. Marttala, and A. Stenborg A comparison of three different methods to evaluate endothelium-dependent vasodilatation in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study Arterioscler Thromb Vasc Biol 25 2005 2368 2375
10. S.C. Barnes, P.O. Collinson, G. Galasko, A. Lahiri, and R. Senior Evaluation of N-terminal pro-B type natriuretic peptide analysis on the Elecsys 1010 and 2010 analysers Ann Clin Biochem 41 2004 459 463
11. A.S. Levey, T. Greene, J.W. Kusek, G.J. Beck MDRD Study Group A simplified equation to predict glomerular filtration rate from serum creatinine J Am Soc Nephrol 11 2000 155A
12. A.H. Wu Serial testing of B-type natriuretic peptide and NTpro-BNP for monitoring therapy of heart failure: the role of biologic variation in the interpretation of results Am Heart J 152 2006 828 834
13. J. Sundström, J. Arnlöv, K. Stolare, and L. Lind Blood pressure-independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance: a population-based study Heart 94 2008 874 878
14. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, P.A. Pellikka, M.H. Picard, M.J. Roman, J. Seward, and J.S. Shanewise Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Working Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiogr 18 2005 1440 1463
15. H. Blackburn, A. Keys, E. Simonson, P. Rautaharju, and S. Punsar The electrocardiogram in population studies: a classification system Circulation 21 1960 1160 1175
16. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
17. M.J. Pencina, R.B. D'Agostino Sr., R.B. D'Agostino Jr., and R.S. Vasan Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172
18. K.M. Eggers, B. Lindahl, P. Venge, and L. Lind B-type natriuretic peptides and their relation to cardiovascular structure and function in a population-based sample of subjects aged 70 years Am J Cardiol 103 2009 1032 1038
19. T.J. Wang, M.G. Larson, D. Levy, E.P. Leip, E.J. Benjamin, P.W. Wilson, P. Sutherland, T. Omland, and R.S. Vasan Impact of age and sex on plasma natriuretic peptide levels in healthy adults Am J Cardiol 90 2002 254 258
20. P. Hildebrandt, P.O. Collinson, R.N. Doughty, A. Fuat, D.C. Gaze, F. Gustafsson, J. Januzzi, J. Rosenberg, R. Senior, and M. Richards Age-dependent values of N-terminal pro-B-type natriuretic peptide are superior to a single cut-point for ruling out suspected systolic dysfunction in primary care Eur Heart J 31 2010 1881 1889
21. O.W. Nielsen, T.A. McDonagh, S.D. Robb, and H.J. Dargie Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population J Am Coll Cardiol 41 2003 113 120
22. P.A. Heidenreich, M.A. Gubens, G.C. Fonarow, M.A. Konstam, L.W. Stevenson, and P.G. Shekelle Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction J Am Coll Cardiol 43 2004 1019 1026
23. M. O'Donoghue, and E. Braunwald Natriuretic peptides in heart failure: should therapy be guided by BNP levels? Nat Rev Cardiol 7 2010 13 20 erratum Nat Rev Cardiol 2010;7:178